Mixed-ligand copper II complexes were studied.
Transcriptional activity of TR, VDR, AR, GR, AhR and PXR receptors was measured.
Target genes in primary human hepatocytes and cancer cell lines were determined.
Two tested compounds activated AhR and induced CYP1A1 and CYP1A2.